Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
13
×
Tags
national blog main
13
×
life sciences
biotech
national top stories
startups
boston blog main
boston top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
national
new york top stories
seattle blog main
seattle top stories
cancer
clinical trials
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
deals
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
novartis
pfizer
tech
technology
wisconsin blog main
wisconsin top stories
amgen
augmented reality
What
year
13
×
drug
medicines
new
chief
disease
medical
officer
pipeline
raised
acquisition
anniversary
approaches
based
big
bn
bristol
businesses
capital
celgene
ceo
clinical
companies
company’s
corporation
diversity
drugs
fda
february
haptx
hirawat
illumagear
infectious
investments
million
modumetal
month
myers
myers’s
open
Language
unset
Current search:
photo
×
year
×
" national blog main "
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More
@xconomy.com
5 years ago
Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More
@xconomy.com
5 years ago
GenCure Plans Adult Stem Cell Lab at San Antonio “Innovation Center”
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push